Cannabinoid Maker Hits Amyris With $881M Trade Secrets Suit
A cannabinoid manufacturer slapped biotech company Amyris with an $881 million trade secrets suit Thursday, alleging the company inked a research and development agreement to boost its stock price and then...To view the full article, register now.
Already a subscriber? Click here to view full article